236 related articles for article (PubMed ID: 11463019)
1. Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?
Edlin BR; Seal KH; Lorvick J; Kral AH; Ciccarone DH; Moore LD; Lo B
N Engl J Med; 2001 Jul; 345(3):211-5. PubMed ID: 11463019
[No Abstract] [Full Text] [Related]
2. Treatment of chronic hepatitis C in active drug users.
Davis GL; Rodrigue JR
N Engl J Med; 2001 Jul; 345(3):215-7. PubMed ID: 11463020
[No Abstract] [Full Text] [Related]
3. [Treatment of hepatitis C in intravenous drug users].
Filoche B
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B252-6. PubMed ID: 12180298
[No Abstract] [Full Text] [Related]
4. Elimination on the agenda for hepatitis C.
Burki T
Lancet Infect Dis; 2014 Jun; 14(6):452-3. PubMed ID: 24971446
[No Abstract] [Full Text] [Related]
5. [Hepatitis C and drug use: epidemiology, screening, natural history and treatment].
Lucidarme D
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B112-20. PubMed ID: 12180278
[No Abstract] [Full Text] [Related]
6. Enhancing hepatitis C treatment uptake and outcomes for injection drug users.
Dore GJ
Hepatology; 2007 Jan; 45(1):3-5. PubMed ID: 17187427
[No Abstract] [Full Text] [Related]
7. The drugs that dare not speak their name: Injecting and other illicit drug use during treatment for hepatitis C infection.
Hopwood M; Treloar C
Int J Drug Policy; 2007 Oct; 18(5):374-80. PubMed ID: 17854725
[TBL] [Abstract][Full Text] [Related]
8. Initiation of methamphetamine abuse during interferon treatment.
Lampinen TM; Greatheart MS; Schilder AJ; Kowdley K
Am J Psychiatry; 2007 Sep; 164(9):1439. PubMed ID: 17728435
[No Abstract] [Full Text] [Related]
9. Is treatment failure for hepatitis C virus infection in HIV-positive drug users associated with a shift in HCV genotypes?
Soriano V; Pérez-Olmeda M; Ríos P; Núñez M; García-Samaniego J; González-Lahoz J
J Acquir Immune Defic Syndr; 2003 Apr; 32(4):465-6. PubMed ID: 12640209
[No Abstract] [Full Text] [Related]
10. Newly acquired hepatitis C--many hurdles from diagnosis until treatment initiation.
Wiegand J
J Gastroenterol Hepatol; 2008 Dec; 23(12):1782-4. PubMed ID: 19120870
[No Abstract] [Full Text] [Related]
11. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.
Edlin BR; Kresina TF; Raymond DB; Carden MR; Gourevitch MN; Rich JD; Cheever LW; Cargill VA
Clin Infect Dis; 2005 Apr; 40 Suppl 5(Suppl 5):S276-85. PubMed ID: 15768335
[TBL] [Abstract][Full Text] [Related]
12. [Hepatitis B virus and celiac disease].
Narváez Rodríguez I; Jiménez Jaén C
Gastroenterol Hepatol; 2010 Oct; 33(8):617. PubMed ID: 20434813
[No Abstract] [Full Text] [Related]
13. Beyond interferon side effects: What residual barriers exist to DAA hepatitis C treatment for people who inject drugs?
Madden A; Hopwood M; Neale J; Treloar C
PLoS One; 2018; 13(11):e0207226. PubMed ID: 30500863
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hepatitis C in injection drug users.
Scott LD
Am J Gastroenterol; 2005 Jan; 100(1):5-7. PubMed ID: 15654772
[No Abstract] [Full Text] [Related]
15. Management of hepatitis C in Rhode Island: opportunities for improvement within and beyond the department of corrections.
Berzin T; Allen S; Taylor L; Rich J; Feller E
Med Health R I; 2002 Nov; 85(11):341-4. PubMed ID: 12462866
[No Abstract] [Full Text] [Related]
16. Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: insights from the ATAHC study.
Nguyen OK; Dore GJ; Kaldor JM; Hellard ME;
Int J Drug Policy; 2007 Oct; 18(5):447-51. PubMed ID: 17854736
[TBL] [Abstract][Full Text] [Related]
17. Maximizing the benefits of antiviral therapy for HCV: the advantages of treating side effects.
Gish RG
Gastroenterol Clin North Am; 2004 Mar; 33(1 Suppl):xxiii-xxiv. PubMed ID: 15081104
[No Abstract] [Full Text] [Related]
18. Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy.
Grebely J; Bruneau J; Bruggmann P; Harris M; Hickman M; Rhodes T; Treloar C; ;
Int J Drug Policy; 2017 Sep; 47():26-33. PubMed ID: 28888558
[No Abstract] [Full Text] [Related]
19. Injection drug users can be effectively treated for hepatitis C.
Stancliff S
Am Fam Physician; 2011 Mar; 83(6):647; author reply 648. PubMed ID: 21404974
[No Abstract] [Full Text] [Related]
20. Prisons, prisoners, and hepatitis C.
Ferguson L; Batey R
J Gastroenterol Hepatol; 2010 Jul; 25(7):1184-6. PubMed ID: 20594243
[No Abstract] [Full Text] [Related]
[Next] [New Search]
